Popular terms

Gly topics
Door Assembly
Swimming Goggles
Transverse
Alkoxylate
Fluoropolymer
Air Cleaning
Rotor Shaft
Aspect Ratio
Disconnect
Synchronization
Remote Control
Ethylene Glycol
Surfactant
Combustion
Steviol Glycosides

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Gly patents



      

This page is updated frequently with new Gly-related patent applications.




Date/App# patent app List of recent Gly-related patents
05/19/16
20160142786 
 Television control interface with electronic guide patent thumbnailTelevision control interface with electronic guide
An on-screen menu method and system for controlling the functions of integrated electronic devices and a television schedule system and method for displaying television schedule information on a television screen includes a program guide having a schedule information area that depicts the programs that are being presented on each channel at each time during the day and an interconnected series of menus to control the features of the integrated electronic devices. An input device allows the viewer to move a pointer over different interactive areas of the guide and the function performed when the area is activated is displayed in a contextual help window.
Rovi Guides, Inc.


05/19/16
20160141646 
 Fuel cell vehicle coolant having improved storage stability and  producing the same patent thumbnailFuel cell vehicle coolant having improved storage stability and producing the same
There are provided a stock solution composition for fuel cell vehicle coolant used by dilution with a diluent comprising water and a method for producing the same, and further a fuel cell vehicle coolant composition having improved storage stability and a method for producing the same. The present invention relates to a method for producing a stock solution composition for fuel cell vehicle coolant, wherein the stock solution composition comprises at least one ethylene glycol compound selected from the group consisting of ethylene glycol, diethylene glycol, and triethylene glycol, and is used by dilution with a diluent comprising water, and the method comprises the following steps: (a) a step of selecting as a raw material an ethylene glycol compound having an ethylene glycol monoformate content of 60 ppm or less; or (b) a step of selecting as a raw material an ethylene glycol compound, wherein a 50% by mass aqueous solution of the ethylene glycol compound has a conductivity of 4.5 μs/cm or less after heating..
Toyota Jidosha Kabushiki Kaisha


05/19/16
20160139162 
 Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase for modulation of cannabinoid receptors patent thumbnailInhibitors of fatty acid amide hydrolase and monoacylglycerol lipase for modulation of cannabinoid receptors
Disclosed are compounds and compositions that inhibit the action of fatty acid amide hydrolase (faah) and monoacylglycerol lipase (mgl), methods of inhibiting faah and mgl, methods of modulating cannabinoid receptors, and methods of treating various disorders related to modulation of cannabinoid receptors.. .
Northeastern University


05/19/16
20160139160 
 Cardiovascular disease risk assessment patent thumbnailCardiovascular disease risk assessment
The invention provides improved methods for analyzing cardiovascular disease risk. According to the invention, an algorithm that considers ldl and hdl subfractions, along with lp(a) provides significant improvement in predicting cvd versus standard assays that include standard risk factors.
Boston Heart Diagnostic Corporation


05/19/16
20160139144 
 Assays for detection of phenylalanine ammonia-lyase and antibodies to phenylalanine ammonia-lyase patent thumbnailAssays for detection of phenylalanine ammonia-lyase and antibodies to phenylalanine ammonia-lyase
Provided herein are methods of detecting the presence of a pegylated enzyme, an enzyme-specific antibody (e.g., a neutralizing antibody or of a particular isotype), or a polyethylene glycol (peg)-specific antibody in a sample, such as a bodily fluid or tissue of a patient. In certain embodiments, the enzyme is phenylalanine ammonia-lyase (pal), such as anabaena variabilis (av) pal administered to the patient as part of an enzyme substitution therapy for diseases or disorders, such as phenylketonuria (pku), or cancer therapy..
Biomarin Pharmaceutical Inc.


05/19/16
20160139136 
 Rapid fluorescence tagging of glycans and other biomolecules with enhanced ms signals patent thumbnailRapid fluorescence tagging of glycans and other biomolecules with enhanced ms signals
Reagents comprising ms active, fluorescent molecules with an activated functionality for reaction with amines useful in tagging biomolecules such as n-glycans and uses thereof are taught and described.. .
Waters Technologies Corporation


05/19/16
20160138198 
 Normal pressure dyeable polyester fiber and  producing the same patent thumbnailNormal pressure dyeable polyester fiber and producing the same
Disclosed is a fiber made of a polyester resin, wherein the polyester resin is a copolymer including a dicarboxylic acid component and a glycol component; of the dicarboxylic acid component, 80 mol % or more is accounted for by a terephthalic acid component, 4.0 to 12.0 mol % is accounted for by a cyclohexane dicarboxylic acid component, and 2.0 to 8.0 mol % is accounted for by an adipic acid component; and the glycol component contains an ethylene glycol component as a main component thereof. A polyester fiber is thereby provided which can be dyed with excellent deep color property and fastness property in dyeing under a normal pressure environment and which can offer stable quality and processing performance also by a direct spinning stretching method or other general melt-spinning methods..
Kuraray Co., Ltd.


05/19/16
20160138073 
 Glycated hexapeptide oxidase and use thereof patent thumbnailGlycated hexapeptide oxidase and use thereof
The present invention provides a protein comprising an amino acid sequence in which arginine at position 61 of a protein comprising the amino acid sequence represented by seq id no: 1 is substituted to an amino acid selected from the group consisting of glycine, alanine, valine, leucine, serine, threonine, proline, cysteine, methionine, asparagine, glutamine, and aspartic acid; and a method for measuring a glycated hemoglobin in a sample, wherein the method comprises reacting a glycated hemoglobin in a sample with a protease to produce a glycated hexapeptide, then reacting the produced glycated hexapeptide with the aforementioned protein, and measuring a substance produced or consumed by the reaction.. .
Kyoto University


05/19/16
20160138021 
 Compositions and methods for treating cancer and other diseases patent thumbnailCompositions and methods for treating cancer and other diseases
Aptamers and improved aptamers are provided with enhanced efficacy for binding to target molecules in vivo or for treating cancer or other diseases. Such improvements in aptamers are provided that enhance in vivo efficacy such as binding to the target molecule or enhancing anti-cancer activity.
Memorial Sloan Kettering Cancer Center


05/19/16
20160137995 
 Transglycosylation activity of glycosynthase mutants of an endo-beta-n-acetylglucosaminidase (endo-d) from streptococcus pneumoniae patent thumbnailTransglycosylation activity of glycosynthase mutants of an endo-beta-n-acetylglucosaminidase (endo-d) from streptococcus pneumoniae
The present invention provides for recombinant endo-d and selected mutants that exhibit reduced hydrolysis activity and increased transglycosylation activity for the synthesis of glycoproteins wherein a desired sugar chain is added to a core fucosylated or nonfucosylated glcnac-protein acceptor by transglycosylation. Such recombinant endo-d and selected mutants are useful for efficient glycosylation remodeling of igg1-fc domain..
University Of Maryland, Baltimore


05/19/16
20160137994 

Novel high functional enzyme having modified substrate specificity of human ß-hexosaminidase b and exhibiting protease resistance


Provided is a modified β-subunit of human β-hexosaminidase which has the activity derived from the α-subunit of wild-type human β-hexosaminidase and has the resistance to protease. A protein comprising an amino acid sequence having substitutions of the 312th to the 318th amino acids with glycine, serine, glutamic acid, proline, serine, glycine and threonine in order, respectively, in an amino acid sequence of a β-subunit of wild-type human β-hexosaminidase..
Meiji Pharmaceutical University


05/19/16
20160137977 

Polymer suitable for use in cell culture


A process for making an oligo(alkylene glycol) functionalized co-polyisocyanopeptide, wherein the process includes the steps of: i) copolymerizing a first comonomer of an oligo(alkylene glycol) functionalized isocyanopeptide grafted with a linking group and a second comonomer of a non-grafted oligo(alkylene glycol) functionalized isocyanopeptide, wherein the molar ratio between the first comonomer and the second comonomer is 1:500 and 1:30 and ii) adding a reactant of a spacer unit and a cell adhesion factor to the copolymer obtained by step i), wherein the spacer unit is represented by general formula a-l-b, wherein the linking group and group a are chosen to react and form a first coupling and the cell adhesion factor and group b are chosen to react and form a second coupling, wherein the first coupling and the second coupling are independently selected from the group consisting of alkyne-azide coupling, dibenzocyclooctyne-azide coupling, oxanorbornmadiene-based-azide couplings, vinylsulphone-thiol coupling, maleimide-thiol coupling, methyl methacrylate-thiol coupling, ether coupling, thioether coupling, biotin-strepavidin coupling, amine-carboxylic acid resulting in amides linkages, alcohol-carboxylic acid coupling resulting in esters linkages and nhs-ester (n-hydroxysuccinimide ester)-amine coupling and wherein group l is a linear chain segment having 10-60 bonds between atoms selected from c, n, o and s in the main chain.. .
Stichting Katholieke Universiteit


05/19/16
20160137854 

Stabilization of carbon nanotube coatings to moisture


A method of making cnt films is described in which the film is washed with a mild acid treatment. The method generates a cnt film that is not sensitive to moisture or fluctuations in moisture.
Battelle Memorial Institute


05/19/16
20160137815 

One-part moisture-curable polyurethane composition


A one-part moisture-curable polyurethane composition according to the present technology comprises: a urethane prepolymer (a), a crosslinking agent (b), carbon black (c) and a catalyst (d). The crosslinking agent (b) is at least one type selected from the group consisting of isocyanurate of hexamethylene diisocyanate (b1), allophanate of hexamethylene diisocyanate (b2), a reaction product of hexamethylene diisocyanate with trimethylolpropane (b3), and a reaction product of hexamethylene diisocyanate with glycerin (b4).
The Yokohama Rubber Co., Ltd.


05/19/16
20160137811 

Ionizing radiation resistant polycarbonate resin composition and article comprising the same


A polycarbonate resin composition includes a polycarbonate resin; a polyalkylene glycol compound; and an epoxy ester compound comprising an ester group and an epoxy group. The polycarbonate resin composition can exhibit excellent properties in terms of color stability, hydrolysis resistance, thermal stability, and the like after irradiation with ionizing radiation..
Samsung Sdi Co., Ltd.


05/19/16
20160137776 

Fluorescent polymers and applications thereof


In one aspect, block copolymers are described herein. A block copolymer described herein, in some embodiments, comprises a first block comprising a polymer or oligomer formed from the reaction product of (i) a polycarboxylic acid or a polycarboxylic acid equivalent, (ii) a polyol, and (iii) an amino acid; and a second block comprising a polymer or oligomer that differs from the polymer or oligomer of the first block.
The Penn State Research Foundation


05/19/16
20160137775 

Methoxypolyethylene glycol-polylactic acid block copolymer and preparation method thereof


A methoxypolyethylene glycol-polylactic acid block copolymer is disclosed, the methoxypolyethylene glycol-polylactic acid block copolymer being a block copolymer formed by ring opening polymerization of d,l-lactide and methoxypolyethylene glycol. A mass ratio of the methoxypolyethylene glycol to the d,l-lactide is 1:0.55-0.65 or 1:0.73-0.89 or 1:0.91-0.99.
Suzhou High-tech Bioscience Co., Ltd.


05/19/16
20160137768 

Fluorine-containing oligomer, nano-silica composite particles using the same, and methods for producing both


Wherein r is a hydrogen atom or a methyl group, m is 1, 2, or 3; and when m is 1, r′ is oh group, nh2 group that is unsubstituted or mono- or di-substituted with an alkyl group having 1 to 6 carbon atoms, or a monovalent group derived from an alkylene glycol or polyalkylene glycol group containing an alkylene group having 2 or 3 carbon atoms; when m is 2 or 3, r′ is a divalent or trivalent organic group derived from a diol or triol. The copolymerization reaction is performed using a hydrocarbon-based peroxide or azo compound polymerization initiator.

05/19/16
20160137743 

Glycan-interacting compounds


The present invention provides glycan-interacting antibodies useful in the treatment and prevention of human disease, including cancer. Such glycan-interacting antibodies include monoclonal antibodies, derivatives and fragments thereof as well as compositions and kits comprising them..
Siamab Therapeutics, Inc.


05/19/16
20160137699 

Recombinant fusion antigen gene, recombinant fusion antigen protein and subunit vaccine composition having the same against infection of porcine reproductive and respiratory syndrome virus


The present invention is directed to a recombinant fusion antigen gene, a recombinant fusion antigen protein and a subunit vaccine composition having the same against infection of porcine reproductive and respiratory syndrome virus (prrsv). A recombinant fusion antigen gene, which encodes glycoprotein gp5 with truncated n′-terminal decoy epitope, a linker sequence and membrane protein m, followed by codon optimization, is expressed by a baculovirus expression system in vitro, thereby enhancing a yield of the recombinant fusion antigen protein.
National Pingtung University Of Science And Technology


05/19/16
20160137694 

Peptide and complex of same, scaffold for tissue repair and surface treatment same, and surface treatment solution or set of treatment solutions


Provided are a peptide that enables surface treatment of a scaffold for tissue repair that makes it possible to accelerate the repair of living tissue without using a material that negatively affects the repair of living tissue, a complex containing this peptide, a scaffold for tissue repair surface treated using this peptide or this complex, a surface treatment method for a scaffold for tissue repair using this peptide or this complex, and a treatment solution or set of treatment solutions to be used in this surface treatment method. Surface treatment of a scaffold for tissue repair is conducted by combining glycosaminoglycan and a peptide containing adhesive sites and basic sites each comprising predetermined amino acid residues..
Jms Co., Ltd.


05/19/16
20160137629 

Compounds for binding to the platelet specific glycoprotein iib/iiia and their use for imaging of thrombi


The present invention relates to novel fluorine containing compounds, methods for their preparation, the intermediates of the synthesis, their use as diagnostic agents, especially for imaging of thrombi. The invention relates to positron emission tomography (pet) agents and associated precursor reagents, and methods for producing such radiolaveled agents for imaging of thrombi in a mammalian body.
Piramal Imaging Sa


05/19/16
20160136763 

Bonding material and bonding method using same


A bonding material of a silver paste includes: fine silver particles having an average primary particle diameter of 1 to 50 nanometers, each of the fine silver particles being coated with an organic compound having a carbon number of not greater than 8, such as hexanoic acid; silver particles having an average primary particle diameter of 0.5 to 4 micrometers, each of the silver particles being coated with an organic compound, such as oleic acid; a solvent containing 3 to 7% by weight of an alcohol and 0.3 to 1% by weight of a triol; a dispersant containing 0.5 to 2% by weight of an acid dispersant and 0.01 to 0.1% by weight of phosphate ester dispersant; and 0.01 to 0.1% by weight of a sintering aid, such as diglycolic acid, wherein the content of the fine silver particles is in the range of from 5% by weight to 30% by weight, and the content of the silver particles is in the range of from 60% by weight to 90% by weight, the content of the total of the fine silver particles and the silver particles being not less than 90% by weight.. .
Dowa Electronics Materials Co., Ltd.


05/19/16
20160136302 

Polyethylene glycol based oligomers for coating nanoparticles, nanoparticles coated therewith, and related methods


In a composition aspect of the invention, a nanoparticle coating comprises repeating polyacrylic acid monomers covalently bound together in an aliphatic chain having a plurality of carboxylic acid functional groups and modified carboxylic acid functional groups extending therefrom. A first portion of the modified carboxylic acid functional groups are modified by a peg oligomer having a terminal methoxy functional group and a second portion of the modified carboxylic acid functional groups are modified by a peg oligomer having at least one terminal sulfur moiety..
The Florida State University Research Foundation, Inc.


05/19/16
20160136299 

Glycoengineered antibody drug conjugates


The current disclosure provides binding polypeptides (e.g., antibodies), and targeting moiety conjugates thereof, comprising a site-specifically engineered glycan linkage within native or engineered glycans of the binding polypeptide. The current disclosure also provides nucleic acids encoding the antigen-binding polypeptides, recombinant expression vectors and host cells for making such antigen-binding polypeptides.
Genzyme Corporation


05/19/16
20160136294 

Bifunctional protein anchors


The disclosure relates to the areas of immunology and vaccine delivery. More specifically, it relates to a bacterial vaccine delivery technology with built-in immunostimulatory properties which allow the immobilization of any antigen of interest, without prior antigen modification.
Applied Nanosystems B.v.


05/19/16
20160136291 

Polymers for delivery of factor viii and/or factor ix


In some aspects, a composition comprising a ph-sensitive crosslinked copolymer of methacrylic acid and poly(ethylene glycol) monomethyl ether methacrylate and a therapeutic protein is provided. In some embodiments, the therapeutic protein is a high molecular weight protein such as factor viii or factor ix.
Board Of Regents, The University Of Texas System


05/19/16
20160136281 

Delivery of ibuprofen and other compounds


The present invention generally relates to the transdermal delivery of various compositions. In some aspects, the transdermal delivery may be facilitated by the use of a hostile biophysical environment.
Strategic Science & Technologies, Llc


05/19/16
20160136277 

Ketoprofen-containing aqueous adhesive skin patch


Provided is a water-based patch that contains ketoprofen as an active ingredient, provides high transdermal absorbability of the ketoprofen, and has high safety and high storage stability. The water-based patch contains the ketoprofen, an amine, and polyethylene glycol.
Teikoku Seiyaku Co., Ltd.


05/19/16
20160136224 

Method for preparing a camellia nitidissima chi lipid-lowering and hypoglycemic agent


The present invention discloses a method for preparing a camellia nitidissima chi lipid-lowering and hypoglycemic agent. Active components such as tea polysaccharides, tea polyphenols, and flavones are extracted from camellia nitidissima chi and purified, which are then mixed with pharmaceutical excipients such as hydroxypropyl methyl cellulose, polyvinylpyrrolidone, and triethyl citrate to prepare various pills, tablets, capsules, granules, etc.
Shenzhen Violin Technology Co.,ltd.


05/19/16
20160136213 

Process to suspend cannabis oil in glycerin


The applied for method of inserting cannabis oil into glycerin represents a significant improvement over the current technology today. First, no reliable or food safe suspension mechanism exists in the medical marijuana market today.

05/19/16
20160136123 

Treatment of autophagy-related disorders


The present invention relates to the use of neutral lipids, including triglycerides, diglycerides and monoglycerides which may be used to increase neutral lipids (lipid stores and/or lipid droplets) and neutral lipid stores in order to regulate (in particular, induce) autophagy and treat and/or prevent autophagy related disease states and/or conditions. In one embodiment, the invention relates to the use of neutral lipids and/or trim proteins which may be used to regulate (in particular, induce) autophagy, target autophagic substrates and treat and/or prevent autophagic disease states and/or conditions..
Stc.unm


05/19/16
20160136117 

Bolus dose of hydroxycitric acid with glycerol


A method of delivering a daily dose of hydroxycitric acid in the form of a salt as a single bolus that is as effective or more so than the same amount of active delivered via two or three administrations (b.i.d. Or t.i.d.) using current delivery modalities.
Glykon Technologies Group, Llc


05/19/16
20160135489 

Potato derived flavour enhancing composition and the manufacture thereof


The present invention relates to a potato derived flavour enhancing composition having a dry matter content of at least 3 wt. % and containing per kg of dry matter: •150-900 g of proteinaceous matter; •0-100 g of starch; •0-5 mg of chlorogenic acid; •0-30 mg of glycoalkaloid selected from α-solanine, α-chaconine and combinations thereof; wherein free amino acids represent at least 80 wt.
Conopco, Inc., D/b/a Unilever


05/19/16
20160135475 

Oil and/or fat composition for cooking, producing the same, and reducing oil and/or fat content remaining in cooked material after cooking


Provided is an oil and/or fat composition for cooking comprising: an oil and/or fat; and 0.02 to 0.09% by mass of polyglycerin fatty acid esters, wherein the oil and/or fat in the oil and/or fat composition for cooking consists of one of or a combination of two or more of animal or vegetable oil and/or fats, hydrogenated oils and/or fats thereof, oil and/or fat fractions thereof, and transesterified oils and/or fats thereof, 80% by mass or more of glycerides of the oil and/or fat are triglycerides, the polyglycerin fatty acid esters have an hlb value of 3.5 or lower, and 5 to 50% by mass of constituent fatty acids of the polyglycerin fatty acid esters are an unsaturated fatty acid(s) having 8 to 22 carbon atoms. The composition is capable of efficiently reducing the oil content remaining in a cooked material.
The Nisshin Oillio Group, Ltd.


05/12/16
20160131974 

Method of manufacturing transparent substrate provided with cured film, photosensitive resin composition, photosensitive element, and electrical component


The method of manufacturing a transparent base material provided with a cured film according to the present invention is characterized in that a photosensitive layer composed of a photosensitive resin composition containing a binder polymer, a photopolymerizable compound containing at least one (meth)acrylate compound selected from the group consisting of (meth)acrylate compounds having a skeleton derived from ditrimethylolpropane and (meth)acrylate compounds having a skeleton derived from diglycerol, and a photopolymerization initiator is disposed on a transparent base material, a predetermined portion of the photosensitive layer is cured through irradiation with active light rays, and portions of the photosensitive layer other than the predetermined portion are then removed to form a cured film composed of a cured product of the photosensitive resin composition, the cured film coating part or all of the base material.. .
Hitachi Chemical Company, Ltd.


05/12/16
20160131649 

Microbial glycans as a target of human intelectin


The present disclosure provides for methods of diagnosing and treating bacterial infections. Human intelectin 1 (hintl-1) has been shown to bind selectively to glycan components on bacteria including streptococcus pneumonia, proteus mirabilis, proteus vulgaris, klebsiella pneumonia and yersinia pestis.
Wisconsin Alumni Research Foundation


05/12/16
20160130531 

Aqueous solutions containing a complexing agent in high concentration


Aqueous solution comprising (a) in the range of from 30 to 60% by weight of a complexing agent, selected from the alkali metal salts of methylglycine diacetic acid and the alkali metal salts of glutamic acid diacetic acid, (b) in the range of from 1 to 25% by weight of at least one salt of a sulfonic acid or of an organic acid, percentages referring to the total respective aqueous solution.. .
Basf Se


05/12/16
20160130530 

Liquid detergent composition


The invention relates to a liquid detergent composition comprising at least one anionic surfactant, at least one ethoxylated glycerol compound, at least one organic solvent comprising glycerol, an amount of water not more than 10% by weight in relation to the entirety of the detergent composition, and optionally, a partially or fully neutralized fatty acid. Said composition is suitable for use in unit doses which also comprise a water-soluble capsule for washing clothes.
Kao Corporation, S.a.


05/12/16
20160130491 

Phase-change suspension fluid composition including fumed silica particles and preparing the same


Disclosed are a suspension fluid and a method for preparing the suspension fluid. Particularly, the suspension fluid is prepared by dispersing fumed silica particles in a solvent that includes one or more compounds selected from the group consisting of ethylene glycol and propylene glycol, and water.
Hyundai Motor Company


05/12/16
20160130479 

Starch-based aqueous adhesive compositions and uses thereof


The invention relates to starch-based aqueous adhesive compositions and uses thereof. Provided is an aqueous adhesive composition comprising highly branched starch (hbs) obtained by treatment of starch or starch derivatives with a glycogen branching enzyme, and further comprising a carboxymethyl (cm) polysaccharide derivative, such as a carboxymethyl ether of starch, cellulose or a combination thereof.
CoÖperatie Avebe U.a.


05/12/16
20160130359 

Her2-specific monoclonal antibodies and conjugates thereof


The identification of her2-specific monoclonal antibody m860 is described. The m860 antibody was identified from a human naïve phage display fab library by panning against the extracellular domain of human her2.
The United States Of America, As Represented By The Secretary, Dep Of Health And Human Services


05/12/16
20160130356 

Glycan-interacting compounds and methods of use


The present invention provides glycan-interacting antibodies and methods for producing glycan-interacting antibodies useful in the treatment and prevention of human disease, including cancer. Such glycan-interacting antibodies include monoclonal antibodies, derivatives, and fragments thereof as well as compositions and kits comprising them.
Siamab Therapeutics, Inc.


05/12/16
20160130303 

Glycogen synthase kinase-3 inhibitors


Novel peptide inhibitors of gsk-3, compositions containing same and uses thereof are disclosed. The novel peptide inhibitors are substrate-competitive inhibitors and have an amino acid sequence designed so as to bind to a defined binding site subunit in gsk-3.
Ramot At Tel-aviv University Ltd.


05/12/16
20160130278 

Glycine transporter inhibitor


Which are useful in the prevention or treatment of diseases such as schizophrenia, alzheimer's disease, cognitive impairment, dementia, anxiety disorders (e.g., generalized anxiety disorder, panic disorder, obsessive-compulsive disorder, social anxiety disorder, post-traumatic stress disorder, specific phobias, acute stress disorder), depression, drug dependence, spasm, tremor, pain, parkinson's disease, attention deficit hyperactivity disorder, bipolar disorder, eating disorder, or sleep disorders, which is based on the glycine uptake-inhibiting action.. .

05/12/16
20160130209 

Method for synthesising glycolic acid


The invention relates to a method for synthesising glycolic acid or one of the salts thereof, including the following step: placing glycerol and an oxidising agent in contact with one another in a reaction medium in the presence of a silver-based catalyst on a substrate, said substrate including a material selected from the group consisting of ceo2, basic al2o3 optionally doped with a calcium or cerium oxide, an amphoteric resin, zro2, and a mixture of said materials. The invention also relates to the use of a silver-based catalyst on a substrate that can be used in said method..
UniversitÉ Des Sciences Et Technologies De Lille 1


05/12/16
20160129420 

Preparation chromatography medium


A method for preparing a chromatography medium having the properties of high virus adsorption and high fluidity, and a method for producing a virus vaccine using the chromatography medium are provided. The chromatography medium is obtained by forming a sulfated polysaccharide bound with porous particles having an exclusion limit molecular weight of 6000 da or less when pure water is used as mobile phase and standard polyethylene glycol is used and an average particle size in the range of 30-200 μm..
Jnc Corporation


05/12/16
20160129414 

Phase-change suspension fluid composition including polyethylene oxide particles and manufacturing the same


A suspension fluid prepared by dispersing polyethylene oxide particles into a solvent including water and one or more types of compounds selected from the group consisting of ethylene glycol and propylene glycol, and a method for manufacturing the same. The phase-change suspension fluid can be a shear-thinning fluid showing a constant newtonian behavior in a low shear rate or low frequency region, but showing a non-newtonian behavior appearing as liquid-like suspension in a high shear rate or high frequency region due to viscosity decrease, and is capable of reversible phase changes by the vibration of a vehicle, and therefore, may provide effects of having advantages of a hydraulic bush in a low frequency region and also having advantages of a solid bush in a high frequency region..
Hyundai Motor Company


05/12/16
20160129114 

Liquid composition, process for producing the liquid composition, and ectoparasite controlling agent for use in mammals and avians


A liquid composition comprising (a) 21 to 70 parts by weight of a solvent having no nitrogen atom and having a carbonyl or sulfonyl group in the molecule, (b) 30 to 78.9 parts by weight of at least one component selected from the group consisting of a non-cyclic alcohol, an alkylene glycol, a polyalkylene glycol, a triol, a glycol monoacetate and a glycol monoalkyl ether, (c) 0.001 to 30 parts by weight of a physiologically active ingredient, and (d) 0.001 to 49 parts by weight of water.. .
Nippon Soda Co., Ltd.


05/12/16
20160129076 

Extracellular matrix-binding synthetic peptidoglycans


This disclosure provides extracellular matrix-binding synthetic peptidoglycans comprised of one or more synthetic peptides conjugated to a glycan and methods of their use.. .
Symic Biomedical, Inc.


05/12/16
20160129038 

Materials and methods for preventing and treating microbe-mediated epithelial disorders


The present invention provides pharmaceutical compositions in the form of relatively high molecular weight biocompatible polymers such as polyethylene glycol, optionally supplemented with a protective polymer such as dextran and/or essential pathogen nutrients such as l-glutamine. Also provided are methods for preventing or treating gut-derived sepsis attributable to intestinal pathogens such as pseudomonas aeruginosa by administering high molecular weight polyethylene glycol as well as methods for monitoring the administration of high molecular weight polyethylene glycol, such as in methods of preventing, ameliorating or treating microbe-induced epithelial disorders, as exemplified by gut-derived sepsis.
The University Of Chicago


05/12/16
20160129029 

Therapeutic compositions and methods of treatment with capsianoside-type compounds


The present invention discloses the use of certain compounds as therapeutic agents, and in particular as analgesics and anti-inflammatory agents. Such compounds include, for example, certain diterpene monoglycosides and diterpene diglycosides.
Bmb Patent Holding Corporation


05/12/16
20160128966 

Methods for treating leukopenia and thrombocytopenia


The disclosure provides methods for treating, controlling or mitigating leukopenia (e.g. Neutropenia) and/or thrombocytopenia, for example in the context of cancer chemotherapy, comprising administration of a monoacetyl-diacyl-glycerol compound, as well as compositions useful therefor..
Enzychem Lifesciences Corporation


05/12/16
20160128961 

Dietary omega-3 fatty acid derived glycerophospholipids to treat neuropathic pain


Disclosed are methods and dietary compositions for the treatment and prevention of neuropathic pain and for pain prognosis. Some embodiments may include the administration of a diet rich in omega-3 fatty acids.
Loma Linda University


05/12/16
20160128940 

Docetaxel nano-polymer micelle lyophilized preparation and preparation method thereof


A docetaxel nano-polymer micelle lyophilized preparation is disclosed including methoxypolyethylene glycol-polylactic acid block copolymer carrier material and docetaxel, the docetaxel being is encapsulated in the carrier material. A mass ratio of the docetaxel to the carrier material is 0.01-0.15.
Suzhou High-tech Biosciense Co., Ltd


05/12/16
20160128917 

Personal care compositions


A personal care composition includes a structured cleansing phase; a benefit phase including triglycerides, a cationic deposition polymer, and anionic microcapsules; and a carrier; and methods relating thereto.. .
The Procter & Gamble Company


05/12/16
20160128797 

Imageable biopsy site marker


A biopsy site marker having at least one small marker body or pellet of bioresorbable material such as gelatin, collagen, polylactic acid, polyglycolic acid which has a radiopaque object, preferably with a non-biological configuration. The at least one bioresorbable body or pellet with a radiopaque object is deposited into the biopsy site, by a delivery device that includes an elongated tubular body with a piston slidable within the tubular body.
Senorx. Inc.


05/12/16
20160128371 

Stevia extract containing selected steviol glycosides as flavor, salty and sweetness profile modifier


Stevia extracts with selected major steviol glycosides (reb a, stevioside, reb d, reb c) and minor steviol glycosides and glycosylated diterpene derivative plant molecules, derived from stevia rebaudiana plant are found to improve the perception of flavor and taste perception, which includes the sweet, savory and salty perception in a wide range of food and beverage applications.. .
Purecircle Usa Inc.


05/12/16
20160128370 

Glucosylated steviol glycosides as a flavor modifier


A taste and flavor profile modifying composition is described. The composition includes glucosylated steviol glycosides which can modify the intensity of a taste and/or a flavor in a food or beverage product..
Purecircle Sdn Bhd


05/12/16
20160128347 

Process of compacting a microporous fat powder and compacted fat powder so obtained


A maximum g′i/g′d ratio of more than 2.0, wherein g′ represents the elastic modulus at 10° c. Of a dispersion of 2 wt.



Gly topics: Door Assembly, Swimming Goggles, Transverse, Alkoxylate, Fluoropolymer, Air Cleaning, Rotor Shaft, Aspect Ratio, Disconnect, Synchronization, Remote Control, Ethylene Glycol, Surfactant, Combustion, Steviol Glycosides

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Gly for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Gly with additional patents listed. Browse our RSS directory or Search for other possible listings.


0.3384

5034

2 - 1 - 106